1,043 results

1. pAAV-hSyn1-eYFP (AAV1)

   Viral Prep

   #117382-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-hSyn1-eYFP (#117382). In addition to the viral particles, you will also receive purified pAAV-hSyn1-eYFP plasmid DNA. hSyn-driven eYFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Viviana Gradinaru

   Article

   Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:

   Promoter

   Syn

   Tags

   eYFP

   Available Since

   Aug. 15, 2025

   Availability

   Academic Institutions and Nonprofits only

2. pAAV.cTNT.iCre (AAV9)

   Viral Prep

   #69916-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV.cTNT.iCre (#69916). In addition to the viral particles, you will also receive purified pAAV.cTNT.iCre plasmid DNA. cTnT driven in vivo expression of Cre and tdTomato (separated by IRES sequence). These AAV preparations are suitable purity for injection into animals.

   Depositor

   William Pu

   Article

   Lin et al Circ Res. 2015 Jan 2;116(1):35-45. doi:

   Promoter

   Chicken cardiac troponin T

   Tags

   tdTomato

   Available Since

   July 31, 2025

   Availability

   Academic Institutions and Nonprofits only

3. pX600-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA (AAV6)

   Viral Prep

   #61592-AAV6

   Purpose

   Ready-to-use AAV6 particles produced from pX600-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA (#61592). In addition to the viral particles, you will also receive purified pX600-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA plasmid DNA. CMV-driven expression of SaCas9. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Feng Zhang

   Article

   Ran et al Nature. 2015 Apr 1. doi: 10.1038/nature1

   Promoter

   Tags

   None

   Available Since

   July 16, 2025

   Availability

   Academic Institutions and Nonprofits only

4. pAAV-hSyn-EGFP (AAV11 trial size)

   Viral Prep

   #50465-AAV11.T

   Purpose

   Ready-to-use AAV11 trial size particles produced from pAAV-hSyn-EGFP (#50465). In addition to the viral particles, you will also receive purified pAAV-hSyn-EGFP plasmid DNA. hSyn-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Bryan Roth

   Promoter

   Syn

   Tags

   EGFP

   Available Since

   July 16, 2025

   Availability

   Academic Institutions and Nonprofits only

5. pAAV-CAG-GFP (AAV6)

   Viral Prep

   #37825-AAV6

   Purpose

   Ready-to-use AAV6 particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Promoter

   CAG

   Tags

   GFP

   Available Since

   July 16, 2025

   Availability

   Academic Institutions and Nonprofits only

6. pAAV-CAG-GFP (AAV11 trial size)

   Viral Prep

   #37825-AAV11.T

   Purpose

   Ready-to-use AAV11 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Promoter

   CAG

   Tags

   GFP

   Available Since

   July 16, 2025

   Availability

   Academic Institutions and Nonprofits only

7. pAAV-CAG-emiRFP670 (AAV1)

   Viral Prep

   #197200-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-CAG-emiRFP670 (#197200). In addition to the viral particles, you will also receive purified pAAV-CAG-emiRFP670 plasmid DNA. CAG-driven expression of emiRFP670. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Kiryl Piatkevich

   Article

   Zhang et al Nat Methods. 2023 Sep 4. doi: 10.1038/s4

   Promoter

   Tags

   None

   Available Since

   Feb. 7, 2025

   Availability

   Academic Institutions and Nonprofits only

8. AiP13755: pAAV-AiE0743m_3xC2-minBG-ChR2(H134R)-EYFP-WPRE3-BGHpA (Alias: CN3755) (AAV PHP.eB)

   Viral Prep

   #214846-PHPeB

   Purpose

   Ready-to-use AAV PHP.eB particles produced from AiP13755: pAAV-AiE0743m_3xC2-minBG-ChR2(H134R)-EYFP-WPRE3-BGHpA (Alias: CN3755) (#214846). In addition to the viral particles, you will also receive purified AiP13755: pAAV-AiE0743m_3xC2-minBG-ChR2(H134R)-EYFP-WPRE3-BGHpA (Alias: CN3755) plasmid DNA. minBG-driven expression of ChR2(H134R)-EYFP in striatal cholinergic neurons. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jonathan Ting, The Allen Institute for Brain Science

   Article

   Hunker et al Neuron. 2025 May 21;113(10):1507-1524.e1

   Promoter

   Tags

   EYFP

   Available Since

   Nov. 13, 2024

   Availability

   Academic Institutions and Nonprofits only

9. pGP-AAV-syn-flex-iGABASnFR2(no bind)-WPRE (AAV5)

   Viral Prep

   #218879-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pGP-AAV-syn-flex-iGABASnFR2(no bind)-WPRE (#218879). In addition to the viral particles, you will also receive purified pGP-AAV-syn-flex-iGABASnFR2(no bind)-WPRE plasmid DNA. Syn-driven, Cre-dependent expression of the improved GABA sensor control iGABASnFR2(no bind) (no change in fluorescence). These AAV preparations are suitable purity for injection into animals.

   Depositor

   GENIE Project

   Article

   Kolb et al bioRxiv 2025.03.25.644953

   Promoter

   Syn

   Tags

   None

   Available Since

   Oct. 21, 2024

   Availability

   Academic Institutions and Nonprofits only

10. pGP-AAV-GFAP-iGABASnFR2(no bind)-WPRE (AAV5)

    Viral Prep

    #218873-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pGP-AAV-GFAP-iGABASnFR2(no bind)-WPRE (#218873). In addition to the viral particles, you will also receive purified pGP-AAV-GFAP-iGABASnFR2(no bind)-WPRE plasmid DNA. GFAP-driven expression of the improved GABA sensor control iGABASnFR2(no bind) (no change in fluorescence). These AAV preparations are suitable purity for injection into animals.

    Depositor

    GENIE Project

    Article

    Kolb et al bioRxiv 2025.03.25.644953

    Promoter

    GFAP

    Tags

    None

    Available Since

    Sept. 27, 2024

    Availability

    Academic Institutions and Nonprofits only

11. pAAV-CAG-FLEx-iSeroSnFR (AAV9)

    Viral Prep

    #128486-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-CAG-FLEx-iSeroSnFR (#128486). In addition to the viral particles, you will also receive purified pAAV-CAG-FLEx-iSeroSnFR plasmid DNA. CAG driven, Cre-dependent expression of iSeroSnFR. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Lin Tian

    Article

    Unger et al Cell. 2020 Dec 12. pii: S0092-8674(20)31

    Promoter

    CAG

    Tags

    None

    Available Since

    Sept. 27, 2024

    Availability

    Academic Institutions and Nonprofits only

12. AiP13778 - pAAV-AiE0450h-minBG-iCre(R297T)-BGHpA (Alias: CN3778) (AAV PHP.eB)

    Viral Prep

    #199775-PHPeB

    Purpose

    Ready-to-use AAV PHP.eB particles produced from AiP13778 - pAAV-AiE0450h-minBG-iCre(R297T)-BGHpA (Alias: CN3778) (#199775). In addition to the viral particles, you will also receive purified AiP13778 - pAAV-AiE0450h-minBG-iCre(R297T)-BGHpA (Alias: CN3778) plasmid DNA. Cre recombinase expression in striatal medium spiny neurons. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Jonathan Ting, The Allen Institute for Brain Science

    Article

    Hunker et al Neuron. 2025 May 21;113(10):1507-1524.e1

    Promoter

    Tags

    None

    Available Since

    July 15, 2024

    Availability

    Academic Institutions and Nonprofits only

13. pAAV-CAG-tTA (AAV2)

    Viral Prep

    #99118-AAV2

    Purpose

    Ready-to-use AAV2 particles produced from pAAV-CAG-tTA (#99118). In addition to the viral particles, you will also receive purified pAAV-CAG-tTA plasmid DNA. CAG-driven expresssion of tetracycline-controlled transactivator (tTA). These AAV preparations are suitable purity for injection into animals.

    Depositor

    Viviana Gradinaru

    Article

    Chan et al Nat Neurosci. 2017 Aug;20(8):1172-1179.

    Promoter

    CAG

    Tags

    None

    Available Since

    June 26, 2024

    Availability

    Academic Institutions and Nonprofits only

14. pAAV-CAG-eYFP (AAV5)

    Viral Prep

    #104055-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV-CAG-eYFP (#104055). In addition to the viral particles, you will also receive purified pAAV-CAG-eYFP plasmid DNA. CAG-driven eYFP expression control. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Viviana Gradinaru

    Article

    Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:

    Promoter

    CAG

    Tags

    EYFP

    Available Since

    Sept. 27, 2023

    Availability

    Academic Institutions and Nonprofits only

15. AAV-Syn-H2B-jGCaMP8s-WPRE (AAV1)

    Viral Prep

    #176749-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from AAV-Syn-H2B-jGCaMP8s-WPRE (#176749). In addition to the viral particles, you will also receive purified AAV-Syn-H2B-jGCaMP8s-WPRE plasmid DNA. Syn-driven expression of histone H2B fused to calcium sensor GCaMP8s. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Loren Looger

    Promoter

    Syn

    Tags

    None

    Available Since

    Aug. 25, 2023

    Availability

    Academic Institutions and Nonprofits only

16. AAV-Syn-H2B-jGCaMP8s-WPRE (AAV Retrograde)

    Viral Prep

    #176749-AAVrg

    Purpose

    Ready-to-use AAV Retrograde particles produced from AAV-Syn-H2B-jGCaMP8s-WPRE (#176749). In addition to the viral particles, you will also receive purified AAV-Syn-H2B-jGCaMP8s-WPRE plasmid DNA. Syn-driven expression of histone H2B fused to calcium sensor GCaMP8s. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Loren Looger

    Promoter

    Syn

    Tags

    None

    Available Since

    Aug. 25, 2023

    Availability

    Academic Institutions and Nonprofits only

17. AAV-mDlx-jGCaMP8f-WPRE (AAV Retrograde)

    Viral Prep

    #176753-AAVrg

    Purpose

    Ready-to-use AAV Retrograde particles produced from AAV-mDlx-jGCaMP8f-WPRE (#176753). In addition to the viral particles, you will also receive purified AAV-mDlx-jGCaMP8f-WPRE plasmid DNA. mDlx-driven expression of ultrafast calcium sensor GCaMP8f. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Loren Looger

    Promoter

    mDlx

    Tags

    None

    Available Since

    July 21, 2023

    Availability

    Academic Institutions and Nonprofits only

18. pAAV-hSynapsin1-axon-GCaMP6s-P2A-mKate2 (AAV9)

    Viral Prep

    #112004-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-hSynapsin1-axon-GCaMP6s-P2A-mKate2 (#112004). In addition to the viral particles, you will also receive purified pAAV-hSynapsin1-axon-GCaMP6s-P2A-mKate2 plasmid DNA. Synapsin-driven, axon-targeted GCaMP6s calcium sensor and bicistronic mKate2 expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Lin Tian

    Article

    Broussard et al Nat Neurosci. 2018 Sep;21(9):1272-1280.

    Promoter

    Syn

    Tags

    mKate2

    Available Since

    Feb. 14, 2022

    Availability

    Academic Institutions and Nonprofits only

19. pAAV-EF1a-iDreV (AAV PHP.eB)

    Viral Prep

    #140136-PHPeB

    Purpose

    Ready-to-use AAV PHP.eB particles produced from pAAV-EF1a-iDreV (#140136). In addition to the viral particles, you will also receive purified pAAV-EF1a-iDreV plasmid DNA. EF1a-driven, light-inducible iDreV recombinase for spatiotemporally precise optogenomic modifications. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Hongkui Zeng

    Article

    Yao et al Nat Methods. 2020 Mar 23. pii: 10.1038/s

    Promoter

    EF1a

    Tags

    None

    Available Since

    Nov. 29, 2021

    Availability

    Academic Institutions and Nonprofits only

20. pAAV-EF1a-iDreV (AAV1)

    Viral Prep

    #140136-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-EF1a-iDreV (#140136). In addition to the viral particles, you will also receive purified pAAV-EF1a-iDreV plasmid DNA. EF1a-driven, light-inducible iDreV recombinase for spatiotemporally precise optogenomic modifications. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Hongkui Zeng

    Article

    Yao et al Nat Methods. 2020 Mar 23. pii: 10.1038/s

    Promoter

    EF1a

    Tags

    None

    Available Since

    Oct. 28, 2021

    Availability

    Academic Institutions and Nonprofits only